BioSpace News Archive

Boston Scientific Corporation (NYSE: BSX) announced it has received CE Mark and initiated a limited market release of the fourth generation Vercise Genus™ Deep Brain Stimulation (DBS) System in Europe

Since 1974, OXY® has been a go-to brand for strong and effective solutions for stubborn teen acne. But acne can affect all ages. Today we proudly announce OXY® Total Care® daily acne therapy for all ages and acne-prone skin types

Albireo Pharma, Inc. (Nasdaq: ALBO), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, announced today the pricing of its previously announced underwritten public offering of 4,000,000 shares of its common stock at a price to the public of $40.00 per share.

SonoScape Medical Corporation introduced its new generation high-end ultrasound systems: the ELITE series, integrating artificial intelligent solutions, advanced features, and remarkably improved system processing capability.

Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), the only company to provide customizable, incision-free therapies which combine real-time Magnetic Resonance Imaging (“MRI”), thermal ultrasound and closed-loop temperature feedback control for the radiation-free ablation of diseased tissue, announced today that management will present an update on the Company’s business at the Cantor Virtual Global Healthcare Conference

Baxter International Inc. (NYSE:BAX), a leading global medical products company, will host a conference call to discuss its third-quarter 2020 financial results on Thursday, October 29, 2020, at 7:30 a.m. Central Time.

Vivera Pharmaceuticals, Inc. is pleased to announce the launch of an exclusive partnership with OmeCare, a leading CLIA-certified global clinical laboratory provider.

LightForce Orthodontics, makers of the world’s first and only fully customizable 3D-printed bracket system, announced it raised a $14 million Series B round led by Tyche Partners with follow-on investment from Matrix Partners and AM Ventures.

Stand Up for APA, a nonprofit working to ensure that all women in the United States receive access to the most accurate non-invasive prenatal testing (NIPT) options, today applauded the American College of Obstetricians and Gynecologists’ (ACOG) new set of guidelines that support NIPT use for all pregnant women, regardless of age or baseline risk.

A recent study published in the Journal of the American Medical Association Neurology demonstrates for the first time the feasibility of Hyperfine’s Swoop™ Portable MRI System to obtain bedside neuroimaging for critically-ill patients in the intensive care unit settings.